N/A
Manufactured by Avet Pharmaceuticals Inc
50,885 FDA adverse event reports analyzed
Last updated: 2026-04-14
ANASTROZOLE TABLETS is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Avet Pharmaceuticals Inc. The most commonly reported adverse reactions for ANASTROZOLE TABLETS include FATIGUE, NAUSEA, DIARRHOEA, ARTHRALGIA, ALOPECIA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for ANASTROZOLE TABLETS.
Out of 20,061 classified reports for ANASTROZOLE TABLETS:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 50,885 FDA FAERS reports that mention ANASTROZOLE TABLETS. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include FATIGUE, NAUSEA, DIARRHOEA, ARTHRALGIA, ALOPECIA, HEADACHE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Avet Pharmaceuticals Inc in connection with ANASTROZOLE TABLETS. Always verify the specific product and NDC with your pharmacist.